Working… Menu

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04251182
Recruitment Status : Suspended (COVID-19 Panemic)
First Posted : January 31, 2020
Last Update Posted : February 3, 2021
National Institute on Aging (NIA)
Clinilabs, Inc.
Alzheimer's Association
Information provided by (Responsible Party):
T3D Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : September 2022